MedDataX Logo

HIV Disclosure and Medication Adherence, a Pilot Study

NCT ID: NCT01621412

Last Updated: 2015-12-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-04-30

Study Completion Date

2013-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators believe that disclosure of HIV status could influence medication adherence. If disclosure leads to social support, adherence could be improved. This study purpose is to assess correlation between disclosure and medication adherence, and to describe people whose HIV status has been disclosed to.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pharmacists administer a questionnaire to each consecutive subject taking part in the adherence-enhancing program at the pharmacy of the Department of Ambulatory Care And Community Medicine in Lausanne. This questionnaire assesses disclosure, response to disclosure, and living situation.

Adherence is measured by electronic monitoring and pill count.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Infection

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Medication Adherence HIV infection Disclosure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* HIV Infection
* Enrolled in the adherence-enhancing program

Exclusion Criteria

* Inclusion visit
* Not french or english speaker
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire Vaudois

OTHER

Sponsor Role collaborator

Swiss HIV Cohort Study

NETWORK

Sponsor Role collaborator

Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marie Schneider

Pharmacist, PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marie-Paule Schneider, PhD

Role: PRINCIPAL_INVESTIGATOR

Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

Aurélie Gertsch, PhD-Student

Role: PRINCIPAL_INVESTIGATOR

Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

Olivier Bugnon, Professor

Role: STUDY_CHAIR

Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

Matthias Cavassini, MD

Role: STUDY_CHAIR

Centre Hospitalier Universitaire Vaudois

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Policlinique Médicale Universitaire

Lausanne, Canton of Vaud, Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RSAD-VIH-2011

Identifier Type: -

Identifier Source: org_study_id